One Of World’s Most Famous Drugs Could Unlock Solution For Alzheimer’s

Nov 17, 2026 - 19:00
0 0
One Of World’s Most Famous Drugs Could Unlock Solution For Alzheimer’s
Freedom Is Back In Style - 728x90 Ad

Premium domains for sale

Freedom Is Back In Style

FreedomIsBackInStyle .COM .NET .ORG WhereFreedomIsBackInStyle .COM .NET .ORG
Six-domain portfolio: $300,000 View Domains

An erectile dysfunction drug from South Korea could become the first pill approved in the United States to slow Alzheimer’s disease.

Freedom Is Back In Style - 300x250 Ad

Freedom Is Back
In Style

Premium domains for sale

FreedomIsBackInStyle.com .COM   .NET   .ORG
Packages from $100,000 View Domains

Researchers announced this week that a lower-dose version of the drug — sold as Mvix in South Korea for erectile dysfunction — helped slow mental decline in a yearlong trial of more than 1,500 people with early-stage Alzheimer’s, The Washington Post reported. But the experimental treatment, called AR1001, appeared to work only in those who were not taking other medications for dementia.

Among the roughly 40% of participants who weren’t taking other dementia drugs, the pill slowed decline by about 31% compared with the placebo group. The rest of the participants, those who were on other dementia medications, exhibited little to no benefit. Across the full trial population, the benefit was not statistically significant. Researchers measured decline through assessments that included interviews with the patients and their caregivers about memory, judgment, and their daily lives.

AriBio, the South Korean company repurposing the drug, said it plans to discuss with the Food and Drug Administration whether the trial results are sufficient or whether another trial is needed.

If the low-dose version of Mvix were to get approved, it would be the first pill authorized in the country to slow Alzheimer’s, according to Sharon Sha, a neurologist who directs the Stanford Center for Memory Disorders and led the trial.

Sha presented the group’s findings at the Clinical Trials on Alzheimer’s Disease conference on Monday.

“To have a disease-modifying drug with relatively minimal side effects that is oral would be huge,” she said. “It’s very exciting and promising.”

Reported side effects included diarrhea, dizziness, falls and fainting.

AriBio has been testing the Viagra-like drug since late 2022 at a daily dose of 30 milligrams — less than a third of the 100-milligram dose used for erectile dysfunction.

Richard Oakley, an associate director for research and innovation at Alzheimer’s Society in the United Kingdom, said the results could change the future of Alzheimer’s treatment.

“These topline results are an exciting sign that we could have a totally new treatment for early Alzheimer’s disease that tackles its causes, not just its symptoms,” he said. “[The drug] takes a novel approach, relaxing blood vessels to increase blood flow to the brain. And unlike other disease-modifying treatments that have shown benefits in late-stage trials, it is taken as a once-a-day tablet, which could make treatment simpler.”

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
Fibis

I am just an average American. My teen years were in the late 70s and I participated in all that that decade offered. Started working young, too young. Then I joined the Army before I graduated High School. I spent 25 years in, mostly in Infantry units. Since then I've worked in information technology positions all at small family owned companies. At this rate I'll never be a tech millionaire. When I was young I rode horses as much as I could. I do believe I should have been a cowboy. I'm getting in the saddle again by taking riding lessons and see where it goes.

Freedom Is Back In Style - 728x90 Ad

Premium domains for sale

Freedom Is Back In Style

FreedomIsBackInStyle .COM .NET .ORG WhereFreedomIsBackInStyle .COM .NET .ORG
Six-domain portfolio: $300,000 View Domains

Comments (0)

User